commercial

Digital

Conceptualisation of AI brain and circuit board

Going beyond the hype: Embracing AI for strategic advantage

The transformative potential of artificial intelligence (AI) within medical affairs has been widely discussed, yet, realising its real-world commercial value requires a pragmatic approach t

R&D

Connecting the clinical, regulatory, and commercial dots for...

The path to rare disease product innovation involves interdependencies between clinical, regulatory, and commercial.

Sales & Marketing

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Sales & Marketing

accelerating the trial-to-treatment pathway

Europe’s commercial leaders prepare for a faster trial-to-tr...

By improving cross-functional connectivity and customer choice, life sciences leaders are overcoming Europe’s field access challenges.

Market Access

Too many UK life sciences companies tolerate commercial fail...

A trip to the annual Medica trade fair in Dusseldorf is a must for people like me, looking to keep on top of what’s happening globally in the field of biotech, medical technology, and pharm

R&D

Inside the NCVR evolution in the UK

For years, the UK's clinical research landscape held a frustrating truth: costing and contracting for commercial research needed to evolve if the nation was to remain an attractive option f